DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
ADEFOVIR
4
Small molecule
Approved
Unknown
Unknown
HIV Infections; Hepatitis B, Chronic
DNA polymerase/reverse transcriptase inhibitor
ADEFOVIR
×
Maximum Phase:
4
First Approval:
None
UNII:
6GQP90I798
Molecule Type:
Small molecule
Molecular Formula:
C8H12N5O4P
Molecular Weight:
273.19
AlogP:
-0.44
PSA:
136.38
HBD:
3.0
HBA:
#RotB:
5.0
Source:
ENDOSTATIN
4
Unknown
Approved
Unknown
Unknown
Colorectal Neoplasms; Neoplasms; Carcinoma, Hepatocellular; Head and Neck Neoplasms; Lung Neoplasms; Melanoma; Nasopharyngeal Neoplasms; Carcinoma, Non-Small-Cell Lung
Unknown
ENDOSTATIN
×
Maximum Phase:
4
First Approval:
None
UNII:
67RHC0R671
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ANTRAFENINE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Prostaglandin-H2 D-isomerase inhibitor
ANTRAFENINE
×
Maximum Phase:
4
First Approval:
None
UNII:
21FS93Y6OE
Molecule Type:
Small molecule
Molecular Formula:
C30H26F6N4O2
Molecular Weight:
588.55
AlogP:
7.0
PSA:
57.7
HBD:
1.0
HBA:
#RotB:
7.0
Source:
TILDRAKIZUMAB-ASMN
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
TILDRAKIZUMAB-ASMN
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IDA
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
IDA
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TIOTROPIUM BROMIDE MONOHYDRATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
TIOTROPIUM BROMIDE MONOHYDRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PADELIPORFIN
4
Small molecule
Approved
Unknown
Unknown
Kidney Neoplasms; Urinary Bladder Neoplasms; Carcinoma, Non-Small-Cell Lung; Cholangiocarcinoma; Prostatic Neoplasms, Castration-Resistant; Neoplasms
Unknown
PADELIPORFIN
×
Maximum Phase:
4
First Approval:
None
UNII:
EEO29FZT86
Molecule Type:
Small molecule
Molecular Formula:
C37H43N5O9PdS
Molecular Weight:
840.26
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC; SODIUM CHLORIDE; SODIUM LACTATE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC; SODIUM CHLORIDE; SODIUM LACTATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PIPAMAZINE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
PIPAMAZINE
×
Maximum Phase:
4
First Approval:
None
UNII:
653552FH1N
Molecule Type:
Small molecule
Molecular Formula:
C21H24ClN3OS
Molecular Weight:
401.96
AlogP:
4.53
PSA:
49.57
HBD:
1.0
HBA:
#RotB:
5.0
Source:
ESOMEPRAZOLE MAGNESIUM; NAPROXEN
4
Combination
Approved
GASTROINTESTINAL; OTHER; RHEUMATOLOGY
ORAL
Unknown
Unknown
ESOMEPRAZOLE MAGNESIUM; NAPROXEN
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CEFODIZIME
4
Small molecule
Approved
Unknown
Unknown
Bacterial Infections
Bacterial penicillin-binding protein inhibitor
CEFODIZIME
×
Maximum Phase:
4
First Approval:
None
UNII:
Z31298J4HQ
Molecule Type:
Small molecule
Molecular Formula:
C20H20N6O7S4
Molecular Weight:
584.68
AlogP:
1.0
PSA:
197.4
HBD:
4.0
HBA:
#RotB:
10.0
Source:
AMLODIPINE BESYLATE; PERINDOPRIL ARGININE
4
Combination
Approved
Unknown
ORAL
Unknown
Unknown
AMLODIPINE BESYLATE; PERINDOPRIL ARGININE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
THIOPROPAZATE
4
Small molecule
Approved
Unknown
Unknown
Psychotic Disorders
Unknown
THIOPROPAZATE
×
Maximum Phase:
4
First Approval:
None
UNII:
0JFY081Q2X
Molecule Type:
Small molecule
Molecular Formula:
C23H28ClN3O2S
Molecular Weight:
446.02
AlogP:
4.51
PSA:
36.02
HBD:
0.0
HBA:
#RotB:
7.0
Source:
HYDROCODONE BITARTRATE; PHENYLPROPANOLAMINE HYDROCHLORIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
HYDROCODONE BITARTRATE; PHENYLPROPANOLAMINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IMIDAFENACIN
4
Small molecule
Approved
Unknown
Unknown
Urinary Bladder, Overactive
Muscarinic acetylcholine receptor M3 antagonist
IMIDAFENACIN
×
Maximum Phase:
4
First Approval:
None
UNII:
XJR8Y07LJO
Molecule Type:
Small molecule
Molecular Formula:
C20H21N3O
Molecular Weight:
319.41
AlogP:
3.05
PSA:
60.91
HBD:
1.0
HBA:
#RotB:
6.0
Source:
PENICILLIN G
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
PENICILLIN G
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LOPINAVIR; RITONAVIR
4
Combination
Approved
IMMUNE SYSTEM; OTHER
ORAL
Unknown
Unknown
LOPINAVIR; RITONAVIR
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EPINEPHRINE; PROCAINE HYDROCHLORIDE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
EPINEPHRINE; PROCAINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TRIACETYLDIPHENOLISATIN
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
TRIACETYLDIPHENOLISATIN
×
Maximum Phase:
4
First Approval:
None
UNII:
ZHJ4JHL6HB
Molecule Type:
Small molecule
Molecular Formula:
C26H21NO6
Molecular Weight:
443.46
AlogP:
3.76
PSA:
89.98
HBD:
0.0
HBA:
#RotB:
4.0
Source:
INTERLEUKIN 7
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
INTERLEUKIN 7
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BUCETIN
4
Small molecule
Approved
Unknown
Unknown
Fever; Pain
Unknown
BUCETIN
×
Maximum Phase:
4
First Approval:
None
UNII:
1Z23WB033I
Molecule Type:
Small molecule
Molecular Formula:
C12H17NO3
Molecular Weight:
223.27
AlogP:
1.79
PSA:
58.56
HBD:
2.0
HBA:
#RotB:
5.0
Source:
SOMATROPIN [rDNA origin]
4
Unknown
Approved
DIABETES DRUGS & ENDOCRINOLOGY
INJECTION
Unknown
Unknown
SOMATROPIN [rDNA origin]
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL
4
Combination
Approved
CARDIOVASCULAR; OTHER
ORAL
Unknown
Unknown
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PYRIMETHAMINE; SULFADOXINE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
PYRIMETHAMINE; SULFADOXINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FIPEXIDE
4
Small molecule
Approved
Unknown
Unknown
Attention Deficit Disorder with Hyperactivity
Unknown
FIPEXIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
TG44VME01D
Molecule Type:
Small molecule
Molecular Formula:
C20H21ClN2O4
Molecular Weight:
388.85
AlogP:
2.79
PSA:
51.24
HBD:
0.0
HBA:
#RotB:
5.0
Source:
CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MITOBRONITOL
4
Small molecule
Approved
Unknown
Unknown
Neoplasms
DNA disrupting agent
MITOBRONITOL
×
Maximum Phase:
4
First Approval:
None
UNII:
5UP30YED7N
Molecule Type:
Small molecule
Molecular Formula:
C6H12Br2O4
Molecular Weight:
307.97
AlogP:
-0.78
PSA:
80.92
HBD:
4.0
HBA:
#RotB:
5.0
Source:
TECHNETIUM PENTETATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
TECHNETIUM PENTETATE
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C14H18N3NaO10Tc
Molecular Weight:
509.3
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
XYLITOL
4
Small molecule
Approved
Unknown
Unknown
Bacterial Infections; Cystic Fibrosis; Diabetes Mellitus; Otitis Media with Effusion; Sinusitis; Dental Caries; Otitis Media; Severe Acute Respiratory Syndrome
Unknown
XYLITOL
×
Maximum Phase:
4
First Approval:
None
UNII:
VCQ006KQ1E
Molecule Type:
Small molecule
Molecular Formula:
C5H12O5
Molecular Weight:
152.15
AlogP:
-2.95
PSA:
101.15
HBD:
5.0
HBA:
#RotB:
4.0
Source:
CODEINE PHOSPHATE; PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
CODEINE PHOSPHATE; PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ESTRIOL
4
Small molecule
Approved
Unknown
Unknown
Pregnancy; Menopause; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Atrophic Vaginitis
Estrogen receptor modulator
ESTRIOL
×
Maximum Phase:
4
First Approval:
None
UNII:
FB33469R8E
Molecule Type:
Small molecule
Molecular Formula:
C18H24O3
Molecular Weight:
288.39
AlogP:
2.58
PSA:
60.69
HBD:
3.0
HBA:
#RotB:
0.0
Source:
IOPHENDYLATE
4
Small molecule
Approved
OTHER
INJECTION
Unknown
Unknown
IOPHENDYLATE
×
Maximum Phase:
4
First Approval:
None
UNII:
6V3I57K9UL
Molecule Type:
Small molecule
Molecular Formula:
C19H29IO2
Molecular Weight:
416.34
AlogP:
6.08
PSA:
26.3
HBD:
0.0
HBA:
#RotB:
11.0
Source:
FLUTICASONE FUROATE; VILANTEROL TRIFENATATE
4
Combination
Approved
OTHER
INHALATION
Unknown
Unknown
FLUTICASONE FUROATE; VILANTEROL TRIFENATATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE; SODIUM LACTATE; SODIUM PHOSPHATE, MONOBASIC ANHYDROUS
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE; SODIUM LACTATE; SODIUM PHOSPHATE, MONOBASIC ANHYDROUS
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DARATUMUMAB;HYALURONIDASE-FIHJ
4
Combination
Approved
Unknown
Unknown
Unknown
Unknown
DARATUMUMAB;HYALURONIDASE-FIHJ
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
301
302
303
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA